Brief: Aclaris Therapeutics AppointS Neal Walker As Interim CEO

Aclaris Therapeutics

16/01/2024 12:04

Jan 16 (Reuters) - Aclaris Therapeutics Inc  ACRS.O :
    * ACLARIS THERAPEUTICS INC - NEAL WALKER, CURRENT CHAIRMAN
AND
CO-FOUNDER, APPOINTED AS INTERIM CHIEF EXECUTIVE OFFICER
    * ACLARIS THERAPEUTICS INC - DOUGLAS MANION, M.D. TO STEP
DOWN AS
CHIEF EXECUTIVE OFFICER, PRESIDENT AND MEMBER OF BOARD OF
DIRECTORS
    * ACLARIS THERAPEUTICS INC - CONDUCTING STRATEGIC REVIEW OF
ITS
BUSINESS TO DETERMINE HOW TO OPTIMALLY DEPLOY ITS CAPITAL TO
MAXIMIZE SHAREHOLDER RETURN
    * ACLARIS THERAPEUTICS -ON PRELIMINARY UNAUDITED BASIS,AS OF
DEC
31, 2023, AGGREGATE CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES WAS ABOUT $182 MILLION

Source text for Eikon:  ID:nGNX374YWC 
Further company coverage:  ACRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))